A detailed history of Carmichael Hill & Associates, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 2,713 shares of NVS stock, worth $268,804. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,713
Previous 2,925 7.25%
Holding current value
$268,804
Previous $311,000 0.32%
% of portfolio
0.11%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$106.13 - $120.89 $22,499 - $25,628
-212 Reduced 7.25%
2,713 $312,000
Q4 2023

Jan 23, 2024

SELL
$92.27 - $101.54 $9,503 - $10,458
-103 Reduced 3.4%
2,925 $295,000
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $3,777 - $4,626
-50 Reduced 1.62%
3,028 $274,000
Q2 2022

Aug 05, 2022

SELL
$80.52 - $93.75 $16,506 - $19,218
-205 Reduced 6.24%
3,078 $260,000
Q1 2022

May 16, 2022

SELL
$80.11 - $90.62 $10,013 - $11,327
-125 Reduced 3.67%
3,283 $288,000
Q4 2021

Jan 31, 2022

SELL
$79.7 - $88.13 $31,880 - $35,252
-400 Reduced 10.5%
3,408 $298,000
Q2 2021

Aug 03, 2021

SELL
$85.24 - $94.15 $8,524 - $9,415
-100 Reduced 2.56%
3,808 $347,000
Q2 2020

Aug 05, 2020

SELL
$80.93 - $91.1 $28,325 - $31,884
-350 Reduced 8.22%
3,908 $341,000
Q4 2019

Jan 30, 2020

BUY
$84.35 - $95.37 $12,652 - $14,305
150 Added 3.65%
4,258 $403,000
Q3 2019

Nov 06, 2019

BUY
$85.54 - $94.26 $8,554 - $9,426
100 Added 2.5%
4,108 $357,000
Q1 2019

Apr 23, 2019

SELL
$75.32 - $86.15 $7,531 - $8,615
-100 Reduced 2.43%
4,008 $385,000
Q3 2018

Nov 09, 2018

SELL
$66.94 - $77.43 $4,685 - $5,420
-70 Reduced 1.68%
4,108 $354,000
Q2 2018

Aug 01, 2018

SELL
$64.91 - $73.36 $25,964 - $29,344
-400 Reduced 8.74%
4,178 $316,000
Q1 2018

Apr 27, 2018

SELL
$70.39 - $84.15 $21,117 - $25,245
-300 Reduced 6.15%
4,578 $370,000
Q4 2017

Feb 07, 2018

BUY
$72.33 - $77.64 $352,825 - $378,727
4,878
4,878 $410,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Carmichael Hill & Associates, Inc. Portfolio

Follow Carmichael Hill & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.